JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.01% |
| 2 | Financials | 14.82% |
| 3 | Technology | 12.49% |
| 4 | Healthcare | 9.61% |
| 5 | Consumer Discretionary | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3476
Impinj
PI
$5.62B
| $1.17M | ﹤0.01% |
51,830
+51,820
| +518,200% | +$1.49M |
2016 Q3
5 quarters
|
|
|
CLLS
3477
CALL
Cellectis
CLLS
$141M
| $1.17M | ﹤0.01% |
+40,000
| New | +$1.09M |
2017 Q4
0 quarters
|
|
|
CLLS
3478
PUT
Cellectis
CLLS
$141M
| $1.17M | ﹤0.01% |
+40,000
| New | +$1.09M |
2017 Q4
0 quarters
|
|
3479
STAG Industrial
STAG
$6.89B
| $1.17M | ﹤0.01% |
42,638
+28,083
| +193% | +$785K |
2015 Q4
8 quarters
|
|
|
CO
3480
DELISTED
Global Cord Blood Corporation
CO
| $1.17M | ﹤0.01% |
+117,215
| New | +$1.28M |
2017 Q4
0 quarters
|
|
|
ONCE
3481
PUT
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $1.16M | ﹤0.01% |
+22,600
| New | +$1.62M |
2017 Q4
0 quarters
|
|
|
AGU
3482
PUT
DELISTED
Agrium
AGU
| $1.16M | ﹤0.01% |
10,100
| – | – |
2017 Q2
2 quarters
|
|
|
ELME
3483
Elme Communities
ELME
$156M
| $1.16M | ﹤0.01% |
37,231
-470,832
| -93% | -$15.3M |
2013 Q2
18 quarters
|
|
3484
Andersons Inc
ANDE
$2.23B
| $1.16M | ﹤0.01% |
37,087
+34,627
| +1,408% | +$1.15M |
2013 Q2
18 quarters
|
|
|
VNET
3485
VNET Group
VNET
$1.58B
| $1.15M | ﹤0.01% |
144,666
+142,332
| +6,098% | +$1.04M |
2015 Q2
10 quarters
|
|
3486
First Trust NASDAQ Cybersecurity ETF
CIBR
$17.3B
| $1.15M | ﹤0.01% |
49,660
+2,460
| +5% | +$55K |
2017 Q2
2 quarters
|
|
3487
Ceco Environmental
CECO
$4.21B
| $1.14M | ﹤0.01% |
222,301
-858,004
| -79% | -$5.77M |
2016 Q4
4 quarters
|
|
3488
Midland States Bancorp
MSBI
$679M
| $1.14M | ﹤0.01% |
34,946
-5,193
| -13% | -$169K |
2016 Q3
5 quarters
|
|
|
HYLD
3489
DELISTED
High Yield ETF
HYLD
| $1.13M | ﹤0.01% |
+31,374
| New | +$1.14M |
2017 Q4
0 quarters
|
|
|
BEL
3490
DELISTED
Belmond Ltd.
BEL
| $1.13M | ﹤0.01% |
92,164
+89,314
| +3,134% | +$1.14M |
2016 Q4
4 quarters
|
|
3491
PhenixFIN
PFX
$86.7M
| $1.13M | ﹤0.01% |
10,803
-6,065
| -36% | -$692K |
2016 Q2
6 quarters
|
|
3492
WisdomTree International SmallCap Dividend Fund
DLS
$1.03B
| $1.13M | ﹤0.01% |
14,667
-186
| -1% | -$13.9K |
2013 Q2
18 quarters
|
|
|
MOFG
3493
DELISTED
MidWestOne Financial Group
MOFG
| $1.13M | ﹤0.01% |
33,578
-4,405
| -12% | -$156K |
2016 Q4
4 quarters
|
|
3494
Ituran Location and Control
ITRN
$1.02B
| $1.13M | ﹤0.01% |
32,878
+11,328
| +53% | +$405K |
2016 Q1
7 quarters
|
|
3495
CALL
Lockheed Martin
LMT
$117B
| $1.12M | ﹤0.01% |
3,500
-161,500
| -98% | -$50.9M |
2016 Q4
4 quarters
|
|
|
JP
3496
DELISTED
Jupai Holdings Limited American depositary shares, each representing six ordinary shares
JP
| $1.12M | ﹤0.01% |
60,680
-16,036
| -21% | -$327K |
2017 Q3
1 quarter
|
|
|
ZEUS
3497
DELISTED
Olympic Steel
ZEUS
| $1.12M | ﹤0.01% |
52,120
-3,343
| -6% | -$68.2K |
2016 Q1
7 quarters
|
|
|
GTT
3498
DELISTED
GTT Communications, Inc.
GTT
| $1.12M | ﹤0.01% |
23,841
+15,891
| +200% | +$606K |
2016 Q4
4 quarters
|
|
3499
Conduent
CNDT
$255M
| $1.12M | ﹤0.01% |
69,250
+63,264
| +1,057% | +$990K |
2017 Q1
3 quarters
|
|
|
BPMP
3500
DELISTED
BP Midstream Partners LP Common Units representing Limited Partner Interests
BPMP
| $1.12M | ﹤0.01% |
+54,431
| New | +$991K |
2017 Q4
0 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 812 new, 2,513 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 812 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.